Abstract
Objectives
To determine the effect of mean platelet volume (MPV) to platelet count (PC) ratio on postoperative poor outcomes, early mortality and long-term survival rate in patients undergoing CABG.
Methods
Between February 2016 and September 2018, all patients undergoing CABG in our department were retrospectively reviewed. A total of 213 consecutive patients were included in the study.
Results
Mean age was 61.5 ± 9.7 years and mean follow-up of all patients was 1.4 ± 0.5 years. All patients were divided into two groups as high and low MPV/PC ratio in terms of 3.825 of cut-off point. 72 patients had a high MPV/PC ratio, whereas, 141 patients had low MPV/PC ratio. The rates of reoperation for early vein-graft occlusion, low cardiac output syndrome and respiratory complication were significantly higher in group 1 (p = 0.03, 0.04 and 0.01). The mean hospital length of stay was higher in group 1 (p = 0.03). MPV/PC ratio for reoperation for early vein-graft occlusion; MPV and ejection fraction for low cardiac output syndrome; hyperlipidemia, chronic renal failure history and MPV/PC ratio for sepsis; male gender, CRF history and CPB time for atrial fibrillation; age, congestive heart failure history, myocardial infarction history and CPB time for the early mortality were found to be independent predictors. Peripheral arterial diseases, USAP and MPV/PC ratio were found to be independent predictors for the late mortality.
Conclusions
A high MPV/PC ratio is associated with early vein-graft occlusion and poor postoperative outcomes in the early period after CABG. Furthermore, it has a negative effect on late survival.
Similar content being viewed by others
References
Montrief T, Kofyman A, Long B. Coronary artery bypass graft surgery complications: a review for emergency clinicians. Am J Emerg Med. 2018;36:2289–97.
Kaya U, Kora Y. Predictive value of mean platelet volume in saphenous vein graft disease. Braz J Cariovasc Surg. 2018;33:317–22.
Tsiara S, Elisaf M, Mikhailidis DP. Platelets as predictors of vascular risk: is there a practical index of platelet activitiy? Clin Appl Thromb Hemost. 2003;9:177–90.
Sansanayudh N, Numthavaj P, Muntham D, et al. Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta-analysis. Thromb Haemost. 2015;114:1299–309.
Biricik S, Narcı H, Dündar GA, et al. Mean platelet volume and the ratio of mean platelet volume to platelet count in the diagnosis of acute appendicitis. Am J Emerg Med. 2019;37:411–4.
Azab B, Torbey E, Singh J, et al. Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction. Platelets. 2011;22:557–66.
Oh GH, Chung SP, Park YS, et al. Mean platelet volume to platelet count ratio as a promising predictor of early mortality in severe sepsis. Shock. 2017;47:323–30.
Kesmarky G, Toth K, Habon L, et al. Hemorheological parameters in coronary artery disease. Clin Hemorheol Microcirc. 1998;18:245–51.
Pizzuli L, Yang A, Martin JF, et al. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J. 1998;19:80–4.
Lance MD, Sloep M, Henskens YM, et al. Mean platelet volume as a diagnostic marker for cardiovascular disease: drawbacks of preanalytical conditions and measuring techniques. Clin Appl Thromb Hemost. 2012;18:561–8.
Yazici HU, Poyraz F, Sen N, et al. Relationship between mean platelet volume and ventricular systolic function in patients with metabolic syndrome and ST-elevation myocardial infarction. Clin Invest Med. 2011;34:E330.
Tandhaulow E, Erikssen J, Sanvik L, et al. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991;84:613–7.
Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eu Heart J. 2001;22:1561–71.
Jennings LK. Mechanisms of protect against platelet-mediated atherothrombosis. Thromb Haemost. 2009;102:248–57.
Galis ZS, Khatri JS. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002;90:251–62.
Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17:47–58.
Nakahata N. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther. 2008;118:18–35.
Choudhury A, Chung I, Blann AD, et al. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of “healthy control subjects” and “disease control subjects” in sinus rhythm. J Am Coll Cardiol. 2007;49:1957–64.
Li DZ, Chen QJ, Sun HP, et al. Mean platelet volume to platelet count ratio predicts in-hospital complications and long-term mortality in type A acute aortic dissection. Blood Coagul and Fibrinolysis. 2016;27:653–9.
Bomb R, Oliphant CS, Khouzam RN. Dual antiplatelet therapy after coronary artery bypass grafting in the setting of acute coronary syndrome. Am J Cardiol. 2015;116:148–54.
Patrono C. Aspirin resistance: definition, mechanism and clinical read-outs. J Thtromb Haemost. 2003;1:1710–3.
Gluckman TJ, McLean RC, Schulman SP, et al. Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery. J Am Coll Cardiol. 2011;1:1069–77.
Kayacıoglu I, Gunay R, Saskin H, et al. The role of clopidogrel and acetylsalicylic acid in the prevention of early-phase graft occlusion due to reactive thrombocytosis after coronary artery bypass operation. Heart Surg Forum. 2008;11:E152–157.
Gao G, Zheng Z, Pi Y, et al. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial. J Am Coll Cardiol. 2010;56:1639–43.
Cadroy Y, Bossavy JP, Thalamas C, et al. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation. 2000;101:2823–8.
Greinacher A. Platelet activation by heparin. Blood. 2011;117:4686–7.
Jaumdally RJ, Varma C, Blann AD, et al. Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty. Chest. 2007;132:1532–9.
Gao C, Boylan B, Fang J, et al. Heparin promotes platelet responsiveness by potentiating αIIbβ-mediated outside-in signaling. Blood. 2011;117:4946–52.
Fujita S, Takeda Y, Kizawa S, et al. Platelet volume indices are associated with systolic and diastolic cardiac dysfunction, and left ventricular hypertrophy. BMC Cardiovasc Disord. 2015;15:52.
Acknowledgements
The authors thank to Hüseyin Narcı for his help in preparing this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors report no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tüysüz, M.E., Dedemoğlu, M. High mean platelet volume to platelet count ratio as a predictor on poor outcomes after CABG. Gen Thorac Cardiovasc Surg 68, 459–466 (2020). https://doi.org/10.1007/s11748-019-01202-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-019-01202-7